[This corrects the article DOI: 10.7150/jca.31338.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11212075 | PMC |
| http://dx.doi.org/10.7150/jca.98604 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells and by inhibiting the EphA2/Akt signaling pathway.
Oncol Rep
September 2024
School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the scratch‑wound assay experiments shown in Fig. 3C, two images appeared to overlap [specifically, the '0 h / Control' and 0 h / OP‑B (5 μmol/l) data panels], albeit with different magnification and after a 180° rotation. The authors have examined their original data, and realize that an inadvertent error was made in assembling the images in the figure; specifically, the images of 5 and 10 μmol/l OP‑B treatment for 0 h were both misused.
View Article and Find Full Text PDFErratum: Ophiopogonin-B Suppresses Epithelial-mesenchymal Transition in Human Lung Adenocarcinoma Cells via the Linc00668/miR-432-5p/EMT Axis: Erratum.
J Cancer
June 2024
School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, Nanjing, 210023, P.R. China.
[This corrects the article DOI: 10.7150/jca.31338.
View Article and Find Full Text PDFErratum: Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and β-catenin: Erratum.
J Cancer
May 2024
School of Medicine &Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, P.R. China.
[This corrects the article DOI: 10.7150/jca.60066.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!